| Authors: |
Svalheim KG; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Andresen NK; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway., Bjerre C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Norway., Jakobsen EH; Department of Oncology, Sygehus Sønderjylland, Sønderborg, Denmark., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kaasa S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kyte JA; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. Electronic address: jonky@ous-hf.no. |
